rs3194051 — IL7R I356V

IL7R I356V — A Second Exonic Variant With Modest and Contested MS Association

The IL7R gene¹¹ IL7R gene
IL7R encodes the interleukin-7 receptor alpha chain (IL-7Rα, CD127), which together with the common gamma chain (γc) forms the heterodimeric receptor that binds IL-7 on chromosome 5p13.2 encodes the interleukin-7 receptor alpha chain, an indispensable regulator of T-cell development and homeostasis. The GeneOps database already includes rs6897932 (T244I)²² rs6897932 (T244I)
The exon 6 splicing variant that shifts the membrane-to-soluble receptor balance, raising sIL7R production and amplifying IL-7 signaling, the best-characterized IL7R multiple sclerosis locus. rs3194051 represents a second coding variant in the same gene — an exon 8 missense change, Ile356Val (c.1066A>G) — identified in the same discovery sequencing effort and studied in multiple subsequent association analyses.

Unlike its more famous sibling, rs3194051 (I356V) sits in exon 8, which encodes part of the intracellular domain of IL-7Rα. Isoleucine 356 lies downstream of the transmembrane anchor, in the region responsible for intracellular signaling and association with the JAK1 kinase. The conservative Ile→Val substitution maintains the nonpolar character of this residue, and no functional effect on receptor expression, splicing, JAK1 binding, or IL-7-driven JAK-STAT signaling has been demonstrated³³ no functional effect on receptor expression, splicing, JAK1 binding, or IL-7-driven JAK-STAT signaling has been demonstrated
In contrast, rs6897932 has a well-characterised splicing mechanism with multiple independent validations. This mechanistic gap is the central reason the evidence for rs3194051 is classified as moderate rather than strong.

The Mechanism

Valine and isoleucine are both branched-chain aliphatic amino acids with nearly identical physicochemical properties — the only structural difference is one methylene group. Position 356 is within the intracellular Box 1–Box 2 motif region that participates in JAK1 association and downstream phosphorylation of STAT5⁴⁴ JAK1 association and downstream phosphorylation of STAT5
JAK-STAT signaling is the principal pathway by which IL-7 promotes T-cell survival, proliferation, and differentiation. Computational tools (SIFT, PolyPhen) classify this substitution as tolerated/benign, consistent with the lack of observed functional differences in cell-based assays. ClinVar records this variant as Benign based on three submissions.

The working hypothesis for its MS association — where it has been detected — is that it may act as a tag for nearby regulatory or structural variants in the IL7R locus not yet fully resolved by sequencing, or that it contributes to a polygenic haplotype effect in the context of rs6897932 and other IL7R variants. In the original Swedish discovery study, rs3194051 and rs987107 were identified together as a second IL7R risk haplotype distinct from the rs6897932 haplotype, with rs3194051 G allele frequency being approximately 9% higher in MS cases than controls.

The Evidence

The original identification of rs3194051 came from Zhang et al. 2005⁵⁵ Zhang et al. 2005
Sequencing of IL7R coding exons in Swedish MS cases and controls; both rs3194051 and rs987107 showed significantly higher G allele frequency in cases (~9% excess), who sequenced IL7R coding exons in Swedish MS cases and controls and found the G allele at rs3194051 significantly enriched in cases. However, subsequent independent studies gave conflicting results — several found no significant association, while others observed modest effects consistent with the Swedish finding.

A meta-analysis of eight studies⁶⁶ meta-analysis of eight studies
7,292 MS cases and 8,142 healthy controls pooled; recessive model OR 1.17 (95% CI 1.02–1.33), P < 0.05 gave a borderline-significant recessive OR of 1.17, consistent with the GG homozygote driving any signal. The larger meta-analysis of 27 studies with 9,734 cases and 10,436 controls⁷⁷ 27 studies with 9,734 cases and 10,436 controls
Three IL7RA loci significantly associated with MS: rs6897932, rs3194051, and a third; rs3194051 recessive OR 1.22 (95% CI 1.08–1.38) found OR 1.22 under the recessive model, reaching conventional significance. The signal is weaker than rs6897932 (which achieves genome-wide significance in GWAS), and it is not consistently detected across all ancestry groups or study designs.

Beyond MS, an analysis of HIV/HCV-coinfected patients⁸⁸ an analysis of HIV/HCV-coinfected patients
Cross-sectional study examining IL7R polymorphisms and liver fibrosis severity in 259 HIV/HCV-coinfected patients found that the AA genotype at rs3194051 was associated with significantly higher odds of severe fibrosis, suggesting that IL-7 signaling through this receptor variant modulates immune-driven hepatic damage. This finding adds biological plausibility — even if the mechanism is not proven — by demonstrating that rs3194051 genotype tracks clinically with IL-7-pathway-dependent immune responses.

The GG genotype, which drives the recessive MS association, occurs in approximately 7% of Europeans (consistent with a G allele frequency of ~27% and Hardy-Weinberg equilibrium). In East Asian populations the G allele frequency drops to approximately 6%, making GG homozygotes extremely rare (~0.4%) in these groups, which partly explains why the MS association is detected primarily in European Caucasian cohorts.

Practical Actions

Given the recessive model of association, practical implications are concentrated in GG homozygotes. The absolute excess MS risk conferred by GG at this locus is modest — OR 1.22 over the AA+AG background is smaller than the rs6897932 CC genotype effect and operates on top of the much larger HLA-DRB1*15:01 contribution. Nevertheless, GG carriers who also carry rs6897932 CC (the primary IL7R risk genotype) may have a cumulative IL7R haplotype burden worth considering in the context of other MS genetic risk factors.

The principal actionable parallel is maintaining adequate vitamin D levels, which is the most consistently supported modifiable factor for MS risk reduction and is independently recommended across all IL7R and other immune MS loci. No variant-specific intervention exists for I356V.

For AA homozygotes — the most common genotype — the hepatic fibrosis finding in HIV/HCV coinfection is of specific relevance: if you are coinfected with both viruses, this genotype identifies a subgroup at higher risk of accelerated liver disease, a consideration for timing and intensity of antiviral treatment.

Interactions

The primary IL7R MS haplotype interaction is with rs6897932. The two variants are in partial linkage disequilibrium within the IL7R locus⁹⁹ partial linkage disequilibrium within the IL7R locus
Both variants are in exonic coding sequence; the exon 6 splice-disrupting rs6897932 and the exon 8 missense rs3194051 are on the same chromosome but not in complete LD, allowing independent haplotype combinations, and individuals who carry risk alleles at both loci may have a cumulative IL7R susceptibility haplotype. The I356V variant was co-identified with rs987107 (another IL7R intronic/regulatory variant) in the original Swedish discovery study, and these three variants together may tag a broader IL7R risk haplotype that encompasses both exon 6 splicing dysregulation and exon 8 structural effects.

Outside IL7R, the gene-gene interaction framework established for rs6897932 — where co-occurrence with IL2RA rs2104286 or DDX39B rs2523506 risk alleles multiplies MS risk — likely extends to any IL7R risk haplotype that reduces effective membrane-bound receptor availability or increases aberrant IL-7 signaling. Individuals carrying GG at rs3194051 alongside CC at rs6897932 are expected to lie at the high end of IL7R-mediated MS susceptibility from this gene alone.